Bill Text — Sep 16, 2012
This bill’s text is now available.
Sep 29, 2010
111th Congress, 2009–2010
This bill was introduced on September 29, 2010, in a previous session of Congress, but was not enacted.
Senator from Vermont
Read Text »
Last Updated: Sep 29, 2010
Length: 10 pages
A bill to ensure that rules for the approval of pharmaceutical and biological products do not require violations of medical ethics in the testing of products in humans and vertebrate animals.
9/29/2010--Introduced.Ethical Pathway Act of 2010 - Directs the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs (FDA), to establish a mechanism by which ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 3506 (112th).
This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 3921”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 3921 — 111th Congress: Ethical Pathway Act of 2010. Retrieved from https://www.govtrack.us/congress/bills/111/s3921
“S. 3921 — 111th Congress: Ethical Pathway Act of 2010.” www.GovTrack.us. 2010. November 28, 2015 <https://www.govtrack.us/congress/bills/111/s3921>
|title=S. 3921 (111th)
|accessdate=November 28, 2015
|author=111th Congress (2010)
|date=September 29, 2010
|quote=Ethical Pathway Act of 2010